Advances in Radiomic, Genomic and Radiogenomic Techniques in Pediatric Medulloblastoma
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 February 2025 | Viewed by 689
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue will focus on introducing novel machine learning radiomic approaches as well as genomic and radiogenomic approaches for the management of pediatric medulloblastoma. Specifically, works that aim to develop approaches to improve risk-stratification, outcome prediction, tumor segmentation, or molecular subgroup classification are welcome to be submitted. The goal of this Special Issue is to show works that utilize novel machine learning and deep learning tools that incorporate features from routine imaging and histology, individually or combined, that add value to the current approaches used in the clinical setting, towards improving patient outcomes. This Special Issue will extend on the current literature in terms of the opportunities and advances available in the fields of radiomics and radiogenomics in pediatric brain tumors, an area that is still underserved and is in dire need of more work to aid in the understanding of this disease etiology.
Dr. Marwa Ismail
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medulloblastoma
- pediatrics
- radiomics
- genomics
- segmentation
- deep learning
- classification
- risk-stratification
- molecular subgroups
